BCLS Fund III Investments, LP - Jun 30, 2025 SCHEDULE 13G/A Report for CIDARA THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (CDTX)

Filing Manager: BCLS Fund III Investments, LP
Reporting Manager: BCLS Fund III Investments, LP
Security: CIDARA THERAPEUTICS, INC. Common Stock, $0.0001 par value per share
Symbol: CDTX
Shares outstanding: 25M shares
Disclosed Ownership: 2.5M shares
Ownership: 9.99%
Form type: SCHEDULE 13G/A
Date filed: 8/14/2025, 04:00 PM
Date of event: Jun 30, 2025
Next filing: Nov 14, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BCLS Fund III Investments, LP	9.99%	2.5M	0	2.5M	/s/ Andrew Hack	Andrew Hack, Partner of Bain Capital Life Sciences Investors, LLC